Eli Lilly Stock: Is LLY Stock A Buy After Mounjaro Drives A Strong Third-Quarter Beat? Lily EvansNovember 4, 2023 Eli Lilly (LLY) stock retook its 50-day moving average in early November after diabetes drug, Mounjaro, helped drive a third-quarter beat. X Before yearend, analysts Read More